BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 53891)

  • 1. The fibrinolytic system and haemostasis.
    Chesterman CN
    Thromb Diath Haemorrh; 1975 Nov; 34(2):368-77. PubMed ID: 53891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring activity of fibrinolytic agents. A therapeutic challenge.
    Shafer KE; Santoro SA; Sobel BE; Jaffe AS
    Am J Med; 1984 May; 76(5):879-86. PubMed ID: 6232847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiology of hemostasis. II. Fibrinolysis].
    Sultan Y; Caen J; Allain JP; Meyer D
    Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antiplasmin activity of the E fragments of fibrin and fibrinogen].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1990; (4):511-8. PubMed ID: 2148755
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Fibrinogen degradation of normal and fibrinolytic plasma.
    Scully MF; Kakkar VV
    Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53894
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
    Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector mechanisms and products of the physiological fibrinolytic systems.
    Edgington TS; Plow EF
    Prog Clin Biol Res; 1976; 5():85-120. PubMed ID: 61595
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV
    Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interpretation of hemostatic and fibrinolytic markers].
    Asakura H
    Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New data on the nature and function of the anticoagulation system].
    Kudriashov BA
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):3-12. PubMed ID: 4156880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinogen and fibrin split products and their biological importance].
    Krantz S; Fiedler H; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):1-13. PubMed ID: 4110779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular mechanisms of blood coagulation and fibrinolysis activation].
    Worowski K
    Postepy Hig Med Dosw; 1980; 34(3):189-233. PubMed ID: 6455654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the degradation of fibrinogen Giessen I.
    Bleyl H; Krause WH
    Thromb Res; 1976 Oct; 9(4):329-34. PubMed ID: 136059
    [No Abstract]   [Full Text] [Related]  

  • 20. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.